VANCOUVER, British Columbia – Contextual Genomics, a molecular diagnostics company developing genomic cancer tests, announced today that it has opened a new state-of-the-art commercial laboratory. Located on the campus of the University of British Columbia (UBC), this new laboratory will give cancer patients from Canada and other countries rapid access to the most sophisticated genomic testing.
“Genomic testing will become a standard in cancer care and our new laboratory prepares us to achieve the scale necessary to reduce costs, improve quality, and increase the availability of genomic testing to cancer patients regardless of where they live,” said Chris Wagner, President and CEO of Contextual Genomics. “We made a conscious choice to locate our operations at UBC to be close to a deep pool of world leaders in health care and other research domains.”
Through this laboratory, Contextual Genomics will provide genetic cancer testing to patients across Canada and internationally. The company’s tests will guide diagnosis and enable tailored cancer treatment options to more precisely match a patient’s genomic tumor profile and their clinical needs.
About Contextual Genomics: www.contextualgenomics.com
Contextual Genomics believes that DNA analysis significantly improves human health and geography should not be a barrier to the benefits of using genomic information to guide patient decisions. The company’s first products are actionable molecular tests that guide diagnosis and treatment of cancer.
President and CEO
This release contains forward-looking statements that are not based on historical fact. These forward-looking statements involve risks, uncertainties and other factors that may cause the actual results, events or developments to be materially different from those expressed or implied by such forward-looking statements. Readers are cautioned not to place undue reliance on such forward-looking statements.